HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple abnormalities of ectoglycosyltransferases in cultured fibroblasts from patients with mucolipidosis II: Possible indication for abnormal plasma membrane glycoproteins.

Abstract
Ectoglycosyltransferase activities were measured in cultured normal and mucolipidosis II fibroblasts using endogenous glycoproteins and glycolipids and whole cells. Nucleotide pyrophosphatase, known to interfere with glycosyltransferases, was completely inhibited with 6 mM 5' AMP. Since preliminary experiments have shown multiple abnormalities of ectoglycosyltransferases in mucolipidosis II fibroblasts (Di Donato, unpublished results), galactosyl (Gal)-and N-acetylglucosaminyl (GluNac)-transferase were studied in further detail in confluent and nonconfluent cultures of normal and patient fibroblasts. Activities of both transferases on glycoproteins were higher in nonconfluent cultures. A 50% reduced activity of Gal-transferase was measured in confluent mucolipidosis II cultures and of GluNac-transferase in nonconfluent mucolipidosis II cultures towards incorporation of sugar precursors into glycoproteins. Substrate saturation kinetics of both transferases in mucolipidosis II fibroblasts revealed an abnormal Km for Gal incorporation into endogenous glycoproteins. Glycosylation of glycolipids in mucolipidosis fibroblasts was normal.
AuthorsS D Donato, U N Wiesmann, E Rossi, N Herschkowitz
JournalPediatric research (Pediatr Res) Vol. 11 Issue 10 Pt 2 Pg. 1094-6 (Oct 1977) ISSN: 0031-3998 [Print] United States
PMID904973 (Publication Type: Journal Article)
Chemical References
  • Glycoproteins
  • Membrane Proteins
  • Galactosyltransferases
  • Hexosyltransferases
  • Acetylglucosamine
Topics
  • Acetylglucosamine
  • Cells, Cultured
  • Fibroblasts (enzymology)
  • Galactosyltransferases (metabolism)
  • Glycoproteins (metabolism)
  • Hexosyltransferases (metabolism)
  • Humans
  • In Vitro Techniques
  • Membrane Proteins (metabolism)
  • Mucolipidoses (enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: